• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CIBA VISION JOHOR SDN, BHD. AIR OPTIX AQUA MULTIFOCAL; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CIBA VISION JOHOR SDN, BHD. AIR OPTIX AQUA MULTIFOCAL; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number CBV92003420
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Pain (1994); Ulceration (2116); Burning Sensation (2146); Excessive Tear Production (2235); No Code Available (3191)
Event Date 12/27/2018
Event Type  Injury  
Manufacturer Narrative
The complaint sample has not returned for evaluation.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.This is the first of two reports for the same patient involving two lot numbers.It is unknown which contributed to the event.Refer to 2019-27619-02 for the reported lot number 297021f.(b)(4).The manufacturer internal reference number is: (b)(4).
 
Event Description
As initially reported by a government health agency on 12apr2019 via letter with reference number mw5083962, a female consumer had experienced a sudden onset of severe pain after wearing the alleged contact lenses last (b)(6) 2018.The consumer removed the lenses upon returning home from work and confirmed that she felt an unrelenting pain, excessive tearing and light sensitivity on the eye.She then decided to seek medical help and was later diagnosed with a large unspecified ulceration which was 4.2 x 4.1 in size.The consumer was given antibiotics with an unspecified dose and frequency such as vancomycin and tobramycin.A culture and sensitivity test was done which had showed a positive result of fungus fusarium.She confirmed that the events did not get better even after taking antibiotics and added that could only see hand motion on her right eye.The consumer was also given natamycin drops and oral voriconazole to treat the infection.She had never used the contact lenses while sleeping, swimming or going to hot tubs.The consumer stated that she had never worn the lenses past the time recommended, and had never used water or saliva for cleaning.She also added that she had followed the directions for use and had replaced the case with each new purchase.Scheduled medical visits, laboratory tests, and other treatment modalities were not disclosed.The consumer's eye status was not confirmed.As of 16apr2019, additional information was received from the consumer via telephone.She confirmed that she had also experienced burning and stinging accompanied with pain and was diagnosed to have developed an ulcer overnight on her right eye.The consumer was treated in an emergency room.She indicated that she used a contact lens solution together with the alleged contact lens product.The consumer claimed that both products caused the adverse event.She added that she was very diligent in her eye care routine and had no issues prior to the event date.Medical records containing more data about the event such as treatment, history and laboratory tests were not supplied.The consumer's current eye condition remains unknown as she refused to provide more information about the event.Further details cannot be obtained.
 
Manufacturer Narrative
H.3., h.6.: the actual complaint product was not returned for evaluation.A retained sample from the same complaint lot was tested including package integrity review, complaint history query, review of sterilization process, and trend analysis.The site also conducted manufacturing history records review for the complaint lot, the records showed that the product met specifications at the time of release.A trend related investigation was performed; no trend could be identified.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.There was no nonconformity or deviations during the manufacturing process which related to the nature of the complaint.The root cause could not be determined conclusively.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIR OPTIX AQUA MULTIFOCAL
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
CIBA VISION JOHOR SDN, BHD.
#1 dpb/5 tanjung pelepas port
gelang patah
johor darul takzim johor 81560
MY  81560
MDR Report Key8594054
MDR Text Key144538742
Report Number3006186389-2019-00008
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
PMA/PMN Number
K073459
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup
Report Date 08/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2023
Device Catalogue NumberCBV92003420
Device Lot Number10411178
Was Device Available for Evaluation? No
Date Manufacturer Received07/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATORVASTATIN.; CALCIUM WITH VITAMIN D.; DULOXETINE.; NAPROXEN.; ZOLPIDEM TARTRATE.; ATORVASTATIN; CALCIUM WITH VITAMIN D; DULOXETINE; NAPROXEN; ZOLPIDEM TARTRATE
Patient Outcome(s) Other;
-
-